<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The introduction and the optimization of an alpha-amino substituent based on a series of alpha-hydroxy-beta-N-biaryl <z:chebi fb="91" ids="25698">ether</z:chebi> <z:chebi fb="0" ids="35358">sulfonamide</z:chebi> hydroxamates is described </plain></SENT>
<SENT sid="1" pm="."><plain>The modification leads to a new series of MMP-2/MMP-9 inhibitors with enhanced inhibitory activities and improved ADME properties </plain></SENT>
<SENT sid="2" pm="."><plain>An efficacy study on reducing the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo> in the rat transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAo) model is also demonstrated </plain></SENT>
</text></document>